PenOp Reports Explosive Growth in Personal Pension Plan, Reaching ₦1.46bn in Four Years

PHOTO CREDIT: catalystforbusiness.com

Lagos (Nigeria): The Personal Pension Plan (PPP) has emerged as one of the fastest-growing segments of Nigeria’s pension industry, says the Pension Fund Operators Association of Nigeria (PenOp), stating that the scheme had grown ninefold within the years, rising from N168.63 million in 2021 to N1.46 billion in 2025.

PenOp’s Chief Executive Officer, Mr Oguche Agudah, disclosed while speaking with journalists on Tuesday in Lagos. PPP was formerly known as the Micro Pension Plan (MPP).

“The scheme, which was rebranded to improve its appeal to younger Nigerians and informal sector workers, has grown nearly ninefold in four years.

“In June 2021, N168.63 million was realised, growing to N285.31 million in June 2022, and then N500.63 million by June 2023, moving to N867.72 million in June 2024 and then N1.46 billion in June 2025.

“The Personal Pension Plan is set to remain a cornerstone of Nigeria’s financial inclusion strategy.

“With its simplified branding, tech-driven contributions, and expanding awareness, it is poised to reach more Nigerians in the coming years,” he said.

“Stakeholder collaboration and targeted support will be critical to sustain this momentum and ensure long-term impact,” he added.

Agudah explained that the change of name was a strategic restructuring to align with evolving market realities and customer needs.

He said the new identity communicated flexibility, ownership, and inclusivity, in line with the plan’s objective of enabling every Nigerian, regardless of employment type, to build sustainable retirement savings.

He noted that with simplified branding, technology-driven contributions, and expanding awareness campaigns, the PPP was expected to play a central role in Nigeria’s financial inclusion strategy. 

Related posts

Police, Taiwan Unite Against Transnational Fraud

Tinubu Unveils ₦17bn Grassroots Fund for Development Across 8,804 Wards

UniJos Slams Dalung’s Claims Against Amupitan as False